Physician profile
Carter John Windoft
NPI 1831947803
$536.73
in general payments reported to CMS, 2019-2025
8 companies · $424 in 2025
The $424 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $113 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424 · Travel and Lodging: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $424.22 |
| Travel and Lodging | $112.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $146.72 | 2025 | |
| Coopervision INC. | $112.51 | 2024 | Misight Contact Lens |
| Glaukos Corporation | $77.72 | 2025 | Idosetr |
| Rayner Intraocular Lenses Limited | $67.40 | 2025 | Omidria |
| Alcon Vision LLC | $47.41 | 2025 | Hydrus Microstent, Argos |
| Tarsus Pharmaceuticals, INC. | $33.04 | 2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $32.77 | 2025 | Eylea Hd |
| Amgen INC. | $19.16 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carter Windoft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.